Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Genocea Biosciences Company Profile (NASDAQ:GNCA)

Consensus Ratings for Genocea Biosciences (NASDAQ:GNCA) (?)
Ratings Breakdown: 4 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $32.50 (80.26% upside)

Analysts' Ratings History for Genocea Biosciences (NASDAQ:GNCA)
Show:
DateFirmActionRatingPrice TargetDetailsShare
3/5/2014Needham & Company LLCInitiated CoverageBuyViewTweet This Rating  Share This Rating on StockTwits
3/5/2014Needham & Company LLCInitiated CoverageBuy$22.00ViewTweet This Rating  Share This Rating on StockTwits
3/3/2014Stifel NicolausInitiated CoverageBuy$25.00ViewTweet This Rating  Share This Rating on StockTwits
3/3/2014Cowen and CompanyInitiated CoverageOutperform$40.00ViewTweet This Rating  Share This Rating on StockTwits
3/3/2014Citigroup Inc.Initiated CoverageBuyViewTweet This Rating  Share This Rating on StockTwits
(Data available from 7/25/2012 forward)